Biomarin has granted Ascendis a non-exclusive, worldwide license to use navepegritide, the active ingredient in the latter ...
The U.S. is scrambling to compete with a strategically positioned China on the biotech stage as the Asian country surpasses ...
Well-known for its oncology efforts and making recent headlines for a rumored mega merger with AstraZeneca, Bristol Myers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results